(Q33919225)

30 July 2017

Phosphohexose isomerase/autocrine motility factor/neuroleukin/maturation factor is a multifunctional phosphoprotein (English)

1 reference

30 July 2017

A Haga

1

1 reference

30 July 2017

Y Niinaka

series ordinal

2

1 reference

30 July 2017

A Raz

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

30 July 2017

10

1 reference

Biochimica et Biophysica Acta

inferred from page(s)

published in

1 reference

30 July 2017

1480

1 reference

30 July 2017

235-244

1 reference

30 July 2017

1-2

1 reference

Genetic control of two electrophoretic variants of glucosephosphate isomerase in the mouse (Mus musculus)

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2800%2900075-3

7 January 2021

The detection of hexokinase, glucosephosphate isomerase and phosphoglucomutase activities in polyacrylamide gels after electrophoresis: a novel method using immobilized glucose 6-phosphate dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2800%2900075-3

7 January 2021

84 Phosphoglucose isomerase of human erythrocytes and cardiac tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2800%2900075-3

7 January 2021

Molecular basis of neurological dysfunction coupled with haemolytic anaemia in human glucose-6-phosphate isomerase (GPI) deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2800%2900075-3

7 January 2021

The diagnostic validity of the serum tumor marker phosphohexose isomerase (PHI) in patients with gastrointestinal, kidney, and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2800%2900075-3

7 January 2021

Serum phosphohexose isomerase activities in patients with colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2800%2900075-3

7 January 2021

Serum phosphohexose isomerase in cancer. II. As an index of tumor growth in metastatic carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2800%2900075-3

7 January 2021

Laboratory aids to diagnosis—enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2800%2900075-3

7 January 2021

Molecular cloning and expression of neuroleukin, a neurotrophic factor for spinal and sensory neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2800%2900075-3

7 January 2021

The neurotrophic factor neuroleukin is 90% homologous with phosphohexose isomerase.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2800%2900075-3

7 January 2021

Neuroleukin mediated differentiation induction of myelogenous leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2800%2900075-3

7 January 2021

Suppression of sprouting at the neuromuscular junction by immune sera

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2800%2900075-3

7 January 2021

Inhibition of terminal axonal sprouting by serum from patients with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2800%2900075-3

7 January 2021

Functional interaction and partial homology between human immunodeficiency virus and neuroleukin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2800%2900075-3

7 January 2021

Pathogenesis of infection with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2800%2900075-3

7 January 2021

Autocrine motility factor and its receptor: role in cell locomotion and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2800%2900075-3

7 January 2021

Tumor cell autocrine motility factor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2800%2900075-3

7 January 2021

Migration stimulating activity in serum of breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2800%2900075-3

7 January 2021

Detection of autocrine motility factor in urine as a marker of bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2800%2900075-3

7 January 2021

The crystal structure of a multifunctional protein: phosphoglucose isomerase/autocrine motility factor/neuroleukin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2800%2900075-3

7 January 2021

Autocrine motility factor is a growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2800%2900075-3

7 January 2021

Stimulation of tumor cell motility linked to phosphodiesterase catalytic site of autotaxin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2800%2900075-3

7 January 2021

Angiogenic activity of enzymes.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2800%2900075-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0167-4838%2800%2900075-3

1 reference

7 January 2021

Enhanced casein kinase II activity in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2800%2900075-3

7 January 2021

Selective inhibition of a cyclic nucleotide-independent protein kinase (G-type casein kinase) by naturally occurring glycosaminoglycans

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2800%2900075-3

7 January 2021

Ribofuranosyl-benzimidazole derivatives as inhibitors of casein kinase-2 and casein kinase-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2800%2900075-3

7 January 2021

10.1016/S0167-4838(00)00075-3

Identifiers

DOI

1 reference

30 July 2017

1 reference